As brands struggle with developing content for HTML5, social media and mobile platforms, Pressly has specialized in content marketing strategy, inking deals with The Economist, The Toronto Star, and various Ziff Davis publications, as well as providing branded content services for Global 2000 companies, such as IBM and Toyota.
“We know brands and publishers are looking for a platform to amplify their message on mobile devices – which is a far cry from the keyboard and mouse world. Pressly absolutely nails it with this product,” said Karamdeep Nijjar, a Principal at iNovia Capital.
The cash injection arrives just as Pressly steps out of beta mode during which it worked with 500 testers. They’re now offering a 30-day free trial to the public, with business rates fluctuating between $199 and $499.
“At OMERS Ventures we invest in companies we believe can become global leaders. We think Pressly has huge potential due to its innovative products, strong management team and continuing market traction,” said Derek Smyth, Managing Director of OMERS Ventures.
Below: CEO Jeff Brenner explains how Pressly is moving publishers into the tablet era.
_________________
Research Capital analyst Greg McLeish reiterated his “Speculative Buy” rating and $3.00 target on The FUTR Corporation (The FUTR Corporation… [Read More]
TD Cowen analyst Brian Morrison downgraded BRP (BRP Stock Quote, Chart, News, Analysts, Financials TSX:DOO) to “Hold” from “Buy” and… [Read More]
In an appearance on BNN Bloomberg Market Call on April 14, Raymond James Investment Counsel portfolio manager Chris Blumas said… [Read More]
Beacon analyst Russell Stanley maintained his “Buy” rating on MDA Space (MDA Space Stock Quote, Chart, News, Analysts, Financials TSX:MDA)… [Read More]
Roth Capital Markets initiated coverage of Merlin Labs (Merlin Labs Stock Quote, Chart, News, Analysts, Financials NASDAQ:MRLN) with a “Buy”… [Read More]
Acumen Capital analyst Nick Corcoran has initiated coverage of NeuPath Health (NeuPath Health Stock Quote, Chart, News, Analysts, Financials TSXV:NPTH)… [Read More]